Abstract

To compare the expression pattern of cyclooxygenase-2 (COX-2) in rabbit corneal cells after photorefractive keratectomy (PRK) and laser in situ keratomileusis (LASIK) with the same refractive correction. Department of Ophthalmology, Wakayama Medical University, Wakayama, Japan. Thirty adult albino rabbits were used in the study. Photorefractive keratectomy or LASIK was performed in 1 eye of each animal for the same refractive correction. Each animal was killed after healing intervals up to 6 months. Paraffin sections of the cornea were processed for immunohistochemistry for COX-2 and NFkappaB (p65). After PRK, the central and peripheral corneal epithelia up-regulated COX-2 at 3 days; the central epithelium was positive at 4 weeks. Central and peripheral epithelia returned to negative 3 months later. After LASIK, the central epithelium on the corneal flap up-regulated COX-2 at 1 and 2 weeks; it returned to negative at 4 weeks. The peripheral epithelium was labeled with the antibody. Keratocytes around the stromal incision between the flap and the stromal bed up-regulated COX-2 and returned to negative at 3 months. COX-1 was not detected immunohistochemically in corneal tissue during the healing intervals after both procedures. Nuclear factor kappaB was detected in the cytoplasm and nuclei of migrating corneal epithelial cells 1 day after PRK, was positive in the cytoplasm at 3 days and negative in cytoplasm and nuclei at week and later. Migrating injured epithelium expressed COX-2 until week 4 during post-PRK healing. Central uninjured epithelium as well as stromal keratocytes expressed COX-2 from 3 days to 2 weeks after LASIK. Uninjured peripheral epithelium also expressed COX-2 at 4 weeks. Activation of stromal keratocytes may induce expression of COX-2 in overlying uninjured epithelium via the inflammatory cytokine(s)/NFkappaB pathway.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.